• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Hodgkin’s Lymphoma survivors may have higher cardiovascular disease risk

byAnees DaudandJames Jiang
April 28, 2015
in Cardiology, Chronic Disease, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this study, patients who received treatment for Hodgkin’s Lymphoma had a 3 to 6 fold increased incidence of developing coronary heart disease and heart failure, respectively, compared to the general population.

2. Mediastinal radiotherapy and anthracycline chemotherapy were most associated with increasing the risk of cardiovascular events when evaluating the different therapies that were employed over the years.

Evidence Rating Level: 2 (Good)    

Study Rundown: Hodgkin’s Lymphoma (HL) is one of the most curable malignancies. Since most HL patients are young and living longer, more information regarding the aftereffects of the chemotherapy and radiation used in HL is coming to light. Specifically, some studies have found significantly higher cardiovascular disease amongst survivors of HL. This study, which examined Dutch patients who survived HL for several decades afterwards, found that these patients had a 3 to 6 fold increased incidence of developing coronary heart disease and heart failure, respectively, compared to the general population. Mediastinal radiotherapy and anthracycline chemotherapy were the biggest culprits in increasing the risk of cardiovascular events when evaluating the different therapies that were employed through the years.

The major strength of this study is the long follow up period, which allows the natural course of cardiovascular disease to take place. The major weakness is the significant change in therapy of HL over time, which does affect the relevance of findings from one era to the next. Additionally, the cohort population was relatively small and homogenous, so the results may not generalizable.

Click to read the study, published today in JAMA Internal Medicine

Click to read an invited commentary in JAMA Internal Medicine

RELATED REPORTS

#VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma

#VisualAbstract: Adolescents had an increased risk of all-cause mortality over younger children with Hodgkin lymphoma

#VisualAbstract: Topical calcineurin inhibitor use is associated with an increased risk of lymphoma

Relevant Reading: Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study

In-Depth [retrospective cohort]: The study cohort composed of patients who had received HL treatment at five Dutch university hospitals or cancer centers between the years 1965 and 1995, before the age of 51years, and had survived for five years. Information regarding cardiovascular disease and demographic information was obtained by contacting their general practitioners and cardiologists. Cardiovascular disease included coronary heart disease (including myocardial infarctions and angina), valvular heart disease, and heart failure. There were a total of 2,524 patients included in the final analysis. The median age at time of HL diagnosis was 27.3 years, and median follow up was 20.3yrs (range, 5 – 47 years).

There were a total of 1,713 cardiovascular events identified in 797 patients. The results were reported as standardized incidence ratios (SIRs), which are ratios of the observed and expected outcomes. Those who received therapy for HL had a 3.2-fold increased SIR (95% CI, 3.0-3.5) of developing coronary heart disease and a 6.8-fold increased SIR (95% CI, 5.9-7.6) of developing heart failure compared to the general population. Patients treated at a younger age had higher SIRs than patients treated over the age of 35 years. After considering the different therapies employed for HL, mediastinal radiotherapy (HR 3.6; 95% CI, 2.8-4.6) and anthracycline chemotherapy (HR 1.5; 95% CI, 1.2-1.8) had the strongest association with cardiovascular events. Risk appeared to be higher with increasing doses of the chemotherapy and radiotherapy.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Hodgkin Lymphoma
Previous Post

2 Minute Medicine Rewind April 19 – April 26, 2015

Next Post

Maintenance dialysis linked with increased incidence, worse survival of CPR

RelatedReports

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma
StudyGraphics

#VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma

October 19, 2022
#VisualAbstract: Adolescents had an increased risk of all-cause mortality over younger children with Hodgkin lymphoma
StudyGraphics

#VisualAbstract: Adolescents had an increased risk of all-cause mortality over younger children with Hodgkin lymphoma

January 20, 2022
#VisualAbstract: Topical calcineurin inhibitor use is associated with an increased risk of lymphoma
StudyGraphics

#VisualAbstract: Topical calcineurin inhibitor use is associated with an increased risk of lymphoma

May 26, 2021
#VisualAbstract GHSG HD14: Intensified chemotherapy regimen (BEACOPP+ABVD) improved progression-free survival without improving overall survival over long-term follow-up
StudyGraphics

#VisualAbstract GHSG HD14: Intensified chemotherapy regimen (BEACOPP+ABVD) improved progression-free survival without improving overall survival over long-term follow-up

May 1, 2021
Next Post
APOL1 variants linked to increased risk of renal disease among black patients

Maintenance dialysis linked with increased incidence, worse survival of CPR

Study lends support for interferon-free treatment of hepatitis C

Birinapant shows efficacy in clearing hepatitis B infection [PreClinical]

Opioid policy changes associated with decreased prescription overdose, increased heroin overdose

ED-initiated buprenorphine/naloxone treatment linked to increased enrollment in addiction treatment

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options